Trimodality therapy in EGFR mutation status negative patients with stage IV non-small cell lung cancer
Phase 2
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000006021
- Lead Sponsor
- Iseikai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Active co-morbidities. 2)Symptomatic brain metastasis. 3)Interstitial lung disease. 4)Active infection. 5)Severe heart disease. 6)Massive pleural, cardiac effusion, or ascites needed with treatment. 7)Neurological disorder. 8)Active double cancer. 9)Psychotic disorder. 10)Histology of grave allergic reaction. 11)Pregnancy, breast feeding and supected pregnancy. 12)Patients whose participation in the trial is judged to be inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method